SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-10-076773
Filing Date
2010-08-13
Accepted
2010-08-12 17:38:15
Documents
5
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c04799e10vq.htm 10-Q 250455
2 EXHIBIT 31.1 c04799exv31w1.htm EX-31.1 9099
3 EXHIBIT 31.2 c04799exv31w2.htm EX-31.2 9095
4 EXHIBIT 32.1 c04799exv32w1.htm EX-32.1 3783
5 EXHIBIT 32.2 c04799exv32w2.htm EX-32.2 3854
  Complete submission text file 0000950123-10-076773.txt   277831
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15070 | Film No.: 101012159
SIC: 2834 Pharmaceutical Preparations